OSR Health OSRH
OTC OSRH
$0.19 -0.01 (-5.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

OSR Health (OSRH) Research & Development (2024 - 2025)

Updated

OSR Health (OSRH) reported Research & Development of -$1,794 for Q3 2025, compared with $54,705 a year earlier.

Analysis

OSR Health (OSRH) Research & Development (2024 - 2025) Analysis & Trends

Over the twelve months ended Sep 30, 2025, OSR Health's Research & Development came in at $196,585.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,154.26 Bn 1,122.85 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 625.31 Bn 543.84 Bn 17.26 Bn 3.65 Bn
3 AbbVie 513.85 Bn 486.96 Bn 12.70 Bn 2.34 Bn
4 Merck 366.33 Bn 320.70 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 261.58 Bn 235.26 Bn 12.86 Bn 4.05 Bn
7 Amgen 234.96 Bn 190.36 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 194.32 Bn 168.52 Bn 6.22 Bn 1.76 Bn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn 2.81 Bn
10 OSR Health 6.41 Mn -1.26 Mn 86,605.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -1,794.00
Jun 30, 2025 53,525.00
Mar 31, 2025 90,149.00
Sep 30, 2024 54,705.00
Jun 30, 2024 45,259.00
Mar 31, 2024 46,715.00
API Access

OSR Health Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=OSRH&period=max&api_key=YOUR_API_KEY